Common Contracts

108 similar Letter Agreement contracts by Histogen Inc., My Size, Inc., Predictive Oncology Inc., others

STRICTLY CONFIDENTIAL Bone Biologics Corporation
Letter Agreement • February 26th, 2024 • Bone Biologics Corp • Orthopedic, prosthetic & surgical appliances & supplies • New York
AutoNDA by SimpleDocs
STRICTLY CONFIDENTIAL Lexaria Bioscience Corp.
Letter Agreement • February 16th, 2024 • Lexaria Bioscience Corp. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Bluejay Diagnostics, Inc.
Letter Agreement • December 27th, 2023 • Bluejay Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York
STRICTLY CONFIDENTIAL Harbor Custom Development, Inc.
Letter Agreement • May 15th, 2023 • Harbor Custom Development, Inc. • Operative builders • New York
STRICTLY CONFIDENTIAL ASP Isotopes Inc.
Letter Agreement • April 5th, 2023 • ASP Isotopes Inc. • Miscellaneous chemical products • New York
STRICTLY CONFIDENTIAL Dermata Therapeutics, Inc.
Letter Agreement • March 13th, 2023 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL My Size, Inc. HaYarden 4, pob 1026, Airport City, Israel 7010000 Attn: Ronen Luzon, Chief Executive Officer Dear Mr. Luzon:
Letter Agreement • January 12th, 2023 • My Size, Inc. • Services-prepackaged software • New York

This letter agreement (this “Agreement”) constitutes the agreement between My Size, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive underwriter, agent or advisor in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement other than any Excluded Transactions. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all intern

STRICTLY CONFIDENTIAL Agile Therapeutics, Inc.
Letter Agreement • June 29th, 2022 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Predictive Oncology Inc.
Letter Agreement • May 18th, 2022 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
STRICTLY CONFIDENTIAL Histogen Inc. 10655 Sorrento Valley Road, Suite 200 San Diego, CA 92121 Attn: Steven J. Mento, Ph.D., Executive Chairman, Interim President and Chief Executive Officer Dear Dr. Mento:
Letter Agreement • March 25th, 2022 • Histogen Inc. • Pharmaceutical preparations • New York

This letter agreement (this “Agreement”) constitutes the agreement between Histogen Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connect

STRICTLY CONFIDENTIAL CNS Pharmaceuticals, Inc.
Letter Agreement • January 6th, 2022 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Exicure, Inc.
Letter Agreement • December 16th, 2021 • Exicure, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL
Letter Agreement • November 4th, 2021 • Oramed Pharmaceuticals Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL My Size, Inc.
Letter Agreement • October 28th, 2021 • My Size, Inc. • Services-prepackaged software • New York

This letter agreement (this “Agreement”) constitutes the agreement between My Size, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive underwriter, agent or advisor in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement other than any Excluded Transactions. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all intern

Certain confidential information contained in this document, marked by brackets and asterisk, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed.
Letter Agreement • September 29th, 2021 • ReWalk Robotics Ltd. • Orthopedic, prosthetic & surgical appliances & supplies • New York

This letter agreement (this “Agreement”) constitutes the agreement between ReWalk Robotics Ltd. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company (the “Securities”), including, but not limited to, restructuring of the outstanding warrants of the Company (a “Warrant Restructuring”), during the Term (as hereinafter defined) of this Agreement (each, an “Offering”). The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company

STRICTLY CONFIDENTIAL EyeGate Pharmaceuticals, Inc.
Letter Agreement • August 10th, 2021 • Eyegate Pharmaceuticals Inc • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Intec Pharma Ltd.
Letter Agreement • July 29th, 2021 • Intec Parent Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Xenetic Biosciences, Inc.
Letter Agreement • July 28th, 2021 • Xenetic Biosciences, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Anavex Life Sciences Corp.
Letter Agreement • June 24th, 2021 • Anavex Life Sciences Corp. • Services-commercial physical & biological research • New York
STRICTLY CONFIDENTIAL Enochian BioSciences, Inc. Century City Medical Plaza
Letter Agreement • June 16th, 2021 • Enochian Biosciences Inc • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Uranium Energy Corp.
Letter Agreement • April 8th, 2021 • Uranium Energy Corp • Miscellaneous metal ores • New York
STRICTLY CONFIDENTIAL Innovative Payment Solutions, Inc. 19355 Business Center Drive, #9 Northridge, CA 91324 Attn: William Corbett, Chief Executive Officer
Letter Agreement • March 16th, 2021 • Innovative Payment Solutions, Inc. • Retail-catalog & mail-order houses • New York

This letter agreement (this “Agreement”) constitutes the agreement between Innovative Payment Solutions, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of

AutoNDA by SimpleDocs
STRICTLY CONFIDENTIAL CloudCommerce, Inc.
Letter Agreement • February 22nd, 2021 • Cloudcommerce, Inc. • Retail-miscellaneous retail • New York
STRICTLY CONFIDENTIAL Fuel Tech, Inc. 27601 Bella Vista Parkway Warrenville, IL 60555-1617 Attn: Vincent J. Arnone, Chief Executive Officer Dear Mr. Arnone:
Letter Agreement • February 18th, 2021 • Fuel Tech, Inc. • Industrial & commercial fans & blowers & air purifing equip • New York

This letter agreement (this “Agreement”) constitutes the agreement between Fuel Tech, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in conne

STRICTLY CONFIDENTIAL Caladrius Biosciences, Inc.
Letter Agreement • February 16th, 2021 • Caladrius Biosciences, Inc. • Services-misc health & allied services, nec • New York
STRICTLY CONFIDENTIAL Cyren Ltd.
Letter Agreement • February 16th, 2021 • CYREN Ltd. • Services-prepackaged software • New York
STRICTLY CONFIDENTIAL Arch Therapeutics, Inc.
Letter Agreement • February 12th, 2021 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
STRICTLY CONFIDENTIAL Tyme Technologies, Inc.
Letter Agreement • February 5th, 2021 • Tyme Technologies, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL Citius Pharmaceuticals, Inc.
Letter Agreement • January 27th, 2021 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
STRICTLY CONFIDENTIAL BioSolar, Inc. 27936 Lost Canyon Road, Suite 202 Santa Clarita, CA 91387 Attn: David Lee, Chief Executive Officer
Letter Agreement • January 25th, 2021 • BioSolar Inc • Unsupported plastics film & sheet • New York

This letter agreement (this “Agreement”) constitutes the agreement between BioSolar, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connec

STRICTLY CONFIDENTIAL Senseonics Holdings, Inc. 20451 Seneca Meadows Parkway Germantown, MD 20876-7005 Attn: Timothy T. Goodnow, Chief Executive Officer
Letter Agreement • January 19th, 2021 • Senseonics Holdings, Inc. • Industrial instruments for measurement, display, and control • New York

This letter agreement (this “Agreement”) constitutes the agreement between Senseonics Holdings, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwrigh

STRICTLY CONFIDENTIAL Predictive Oncology Inc.
Letter Agreement • January 12th, 2021 • Predictive Oncology Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
STRICTLY CONFIDENTIAL Staffing 360 Solutions, Inc. 641 Lexington Avenue 27th Floor New York, NY 10022 Attn: Brendan Flood, Chief Executive Officer Dear Mr. Flood:
Letter Agreement • December 31st, 2020 • Staffing 360 Solutions, Inc. • Services-help supply services • New York

This letter agreement (this “Agreement”) constitutes the agreement between Staffing 360 Solutions, Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwr

STRICTLY CONFIDENTIAL Ecoark Holdings, Inc.
Letter Agreement • December 30th, 2020 • Ecoark Holdings, Inc. • Crude petroleum & natural gas • New York
STRICTLY CONFIDENTIAL Histogen Inc. 10655 Sorrento Valley Road, Suite 200 San Diego, CA 92121 Attn: Richard W. Pascoe, Chief Executive Officer Dear Mr. Pascoe:
Letter Agreement • December 29th, 2020 • Histogen Inc. • Pharmaceutical preparations • New York

This letter agreement (this “Agreement”) constitutes the agreement between Histogen Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), that Wainwright shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of securities of the Company (the “Securities”) during the Term (as hereinafter defined) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in connect

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!